Lumito Arrow right Arrow right

Urban Widén

International leader with more than 30 years of experience in the pharma industry, including 20 years as CEO in life science companies such as AstraZene­ca Hungary, Schering-Plough and Organon Biosciences Sweden, AutomationsPart­ner Sweden and Fürst Medicinskt Laboratorium Filial Sweden. Extensive industrial and technical knowledge in diagnostics, automation, digital pathology, global marketing, acquisitions, organic growth and implementation of efficiency measures. Other ongoing assignments: COO Scandinavian ChemoTech AB (publ).  Number of shares: 0 Number of warrants: 0 Dependent of company, independent of larger shareholders.

Read More

Bengt Göran (BG) Svensson

BG Svensson är en erfaren styrelseledamot, både som ordförande och ledamot, i såväl noterade som onoterade bolag. Bakgrund från ledande befattningar inom banking och industrin, samt därefter bl.a. VD på Lunds Universitets Holdingbolag, LUAB, med styrelseuppdrag inom koncernen samt VD på Science Village Scandinavia AB. För närvarande styrelseordförande i SB1 Pharma AB, VD och styrelseledamot i Förvaltnings Aktiebolaget Borgeby samt styrelseledamot i NanoEcho AB (publ). Antal aktier: 0 st Oberoende i förhållande till bolagets större aktieägare samt bolaget och bolagsledningen.

Read More

Ingrid Hultgren

Ingrid Hultgren har en mikrobiologexamen från Uppsala universitet och har nästan 40 års erfarenhet inom life science. Inom in vitro diagnostics har hon arbetat med bakterie- och virusdiagnostikutveckling samt utveckling av instrument och reagens, inklusive antikroppsbaserade reagens, på Pharmacia Diagnostics. Inom medicinsk teknik har hon på Arjo AB (publ) arbetat med produktutveckling, dokumentationssystem, kvalitetsstyrning, och processtyrning av CAPA (korrigerande och förebyggande åtgärder) samt avvikelsehantering. Har tidigare varit styrelseledamot i Arjo AB (publ) och Svenskt Projektforum, samt är för närvarande delägare i Hultgreen Hedge Kommanditbolag. Antal aktier: 0 st Oberoende i förhållande till bolagets större aktieägare samt bolaget och bolagsledningen.

Read More

Roland Andersson

Professor of surgery at Lund University since 2000. Solid clinical experience and clinical and transitional research. Author of more than 500 articles in peer-reviewed journals. Supervisor for about 30 completed graduate students in the areas of cancer, systematic inflammation, organ failure and bowel function.  Other ongoing assignments: Professor of surgery, Lund University. CEO and board member of Foresight Pharma AB. Chairman of the Board of Reccan Diagnostics AB. Board member at Nordic Biotechnology AB, Aqilion AB and Nordic Oncology in Lund AB. Number of shares: 100,000 Number of TO4: 95,000 Independent of company, independent of larger shareholders.

Read More

Ulf Bladin

Medical candidate from Karolinska Institutet, B.Sc. and Master from Stockholm School of Economics. Currently CEO of Prolight Diagnostics. Has previously been, among other things, General Manager, Vice President of EMEA Region at Hycor Biomedical, Vice President Commercial Operations Europe at Thermo Fisher Scientific Immuno Diagnostics Division, Vice President with global responsibility for Marketing, Health Economy, Corporate Communications, Scientific & Regulatory Affairs at Phadia AB. Ulf Bladin has also held leading commercial positions in the pharmaceutical industry at Pfizer and Merck Sharp & Dohme. Other ongoing assignments: CEO and board member of Prolight Diagnostics AB (publ.), board member of  SpectraCure AB (publ), SPCIN AB and UB…

Read More

Stefan Andersson-Engels

Professor of physics at Lund University until 2016. Since 2016 director of Biophotonics at Tyndall National Institute, Ireland. Postdoc at McMasters University in Hamilton, Ontario, Canada. Received Erna Ebeling's award, Swedish Society for Medical Technology and Physics, 2003. First-time candidate for the appointment of the biomedical physics professor at the Royal Institute of Technology, Stockholm 1996. Co-author of more than 200 articles in peer-reviewed journals. Other ongoing assignments: Director of Biophotonics at Tyndall National Institute, Ireland. Chairman of the Board of NanoEcho AB (publ).  Share of shares privately and through related parties: 2,100,000 Number of warrants: 0 Dependent in relation to…

Read More